FILING ANALYSIS · THURSDAY, NOVEMBER 12
Twist Bioscience Corp TWST — 8-K: Results of Operations and Financial Condition
positive
Twist Bioscience reported a record revenue of $459.4 million in Fiscal 2026, a 22% increase over Fiscal 2025, and provided fiscal 2027 revenue guidance of $550M-$560M, representing 21% year-over-year growth at the midpoint. The company's strong top-line revenue growth and expanded gross margin are notable positives.
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →